• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄和性别调整的血清磷酸盐阈值不能改善 CKD 患者的心血管风险评估。

Age- and sex-tailored serum phosphate thresholds do not improve cardiovascular risk estimation in CKD.

机构信息

Division of Nephrology and Dialysis, Department of Internal Medicine and Medical Specialties, Renal Program, Columbus-Gemelli University Hospital, Catholic University of Rome, Rome, Italy.

出版信息

J Nephrol. 2011 Jul-Aug;24(4):446-52. doi: 10.5301/JN.2011.8348.

DOI:10.5301/JN.2011.8348
PMID:21607913
Abstract

BACKGROUND

Disordered metabolism of phosphorus is one of the hallmarks of chronic kidney disease (CKD), resulting in increased cardiovascular morbidity and mortality. Age and sex may affect the metabolism of phosphorus and subsequently its serum level. We evaluated if age- and sex-specific cutoffs for hyperphosphatemia may define cardiovascular risk better than the current guideline cutoffs.

METHODS

We used data from 16,834 subjects participating in the 1999-2006 National Health and Nutrition Examination Survey (NHANES); the prevalence of self-reported cardiovascular disease (CVD) and mortality rates were analyzed in CKD patients for both the classic definitions (CH; i.e., NKF-KDOQI and K-DIGO) and a tailored definition (TH) of hyperphosphatemia by means of regression models adjusted for age, sex, race/ethnicity, smoking status and body mass index. The cutoffs for TH were represented by the 95th percentile of an age- and sex-matched non-CKD population.

RESULTS

Serum phosphorus levels showed an inverse correlation with age (r = -0.12; p<0.001); females showed higher levels than males (3.78 ± 0.54 mg/dL vs. 3.62 ± 0.58 mg/dL; p<0.001). Even if the association between the TH definition and CVD was marginally better compared with the CH definition (odds ratio [OR] = 1.49, 95% confidence interval [95% CI], 1.04-2.13; p=0.030 vs. OR=1.55, 95% CI, 0.98-2.44; p = 0.059), the TH model was not superior in predicting CVD or mortality.

CONCLUSIONS

Our data suggest that a tailored, age- and sex-specific definition of hyperphosphatemia is not superior to conventional definitions in predicting cardiovascular events in patients with CKD.

摘要

背景

磷代谢紊乱是慢性肾脏病(CKD)的特征之一,导致心血管发病率和死亡率增加。年龄和性别可能会影响磷的代谢,进而影响其血清水平。我们评估了针对高磷血症的年龄和性别特异性切点是否比现行指南切点更能明确心血管风险。

方法

我们使用了 1999-2006 年全国健康和营养调查(NHANES)中 16834 名参与者的数据;通过回归模型,在 CKD 患者中分析了经典定义(CH,即 NKF-KDOQI 和 K-DIGO)和高磷血症的定制定义(TH)下的自我报告心血管疾病(CVD)患病率和死亡率,回归模型调整了年龄、性别、种族/民族、吸烟状况和体重指数。TH 的切点表示与年龄和性别匹配的非 CKD 人群的第 95 百分位。

结果

血清磷水平与年龄呈负相关(r = -0.12;p<0.001);女性的水平高于男性(3.78 ± 0.54mg/dL 比 3.62 ± 0.58mg/dL;p<0.001)。尽管与 CH 定义相比,TH 定义与 CVD 的相关性略好(比值比[OR] = 1.49,95%置信区间[95%CI],1.04-2.13;p=0.030 比 OR=1.55,95%CI,0.98-2.44;p = 0.059),但 TH 模型在预测 CVD 或死亡率方面并不占优势。

结论

我们的数据表明,针对高磷血症的定制、年龄和性别特异性定义在预测 CKD 患者的心血管事件方面并不优于传统定义。

相似文献

1
Age- and sex-tailored serum phosphate thresholds do not improve cardiovascular risk estimation in CKD.年龄和性别调整的血清磷酸盐阈值不能改善 CKD 患者的心血管风险评估。
J Nephrol. 2011 Jul-Aug;24(4):446-52. doi: 10.5301/JN.2011.8348.
2
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.慢性肾脏病中磷及钙磷乘积与死亡率的关系
Am J Kidney Dis. 2005 Sep;46(3):455-63. doi: 10.1053/j.ajkd.2005.05.025.
3
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).慢性肾脏病3期和4期患者的血浆甲状旁腺激素水平与心血管疾病患病率:来自肾脏早期评估项目(KEEP)的分析
Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10. doi: 10.1053/j.ajkd.2008.11.029.
4
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.社区中血清磷和钙水平与心血管疾病发病率的关系。
Arch Intern Med. 2007 May 14;167(9):879-85. doi: 10.1001/archinte.167.9.879.
5
Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.血液透析的慢性肾脏病5期患者中25(羟)维生素D不足和缺乏的患病率。
Hemodial Int. 2007 Jul;11(3):315-21. doi: 10.1111/j.1542-4758.2007.00186.x.
6
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.K/DOQI 1-3期慢性肾脏病患者的心血管和肾脏转归:尿白蛋白排泄的重要性
Nephrol Dial Transplant. 2008 Dec;23(12):3851-8. doi: 10.1093/ndt/gfn356. Epub 2008 Jul 18.
7
Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.矿物质代谢与心血管疾病发病率及死亡风险:腹膜透析患者与血液透析患者的比较
Nephrol Dial Transplant. 2006 Sep;21(9):2513-20. doi: 10.1093/ndt/gfl257. Epub 2006 Jun 24.
8
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.血清白蛋白、C反应蛋白、白细胞介素6和胎球蛋白A作为终末期肾病患者营养不良、心血管疾病及死亡率的预测指标。
Am J Kidney Dis. 2006 Jan;47(1):139-48. doi: 10.1053/j.ajkd.2005.09.014.
9
A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.一种基于会诊的方法在预测未来心血管疾病风险方面与SCORE以及一种广泛的基于实验室检查的方法效果相当。
Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):536-40. doi: 10.1097/HJR.0b013e32832b1833.
10
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.血清磷与肾移植受者心血管疾病、全因死亡率或移植失败风险:FAVORIT试验队列的一项辅助研究
Am J Kidney Dis. 2017 Sep;70(3):377-385. doi: 10.1053/j.ajkd.2017.04.014. Epub 2017 Jun 2.